PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds that information is as important as medication in reducing migraine pain

Findings also show that patients report pain relief even when they know they are receiving a placebo

2014-01-09
(Press-News.org) Contact information: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Study finds that information is as important as medication in reducing migraine pain Findings also show that patients report pain relief even when they know they are receiving a placebo BOSTON – The information that clinicians provide to patients when prescribing treatments has long been thought to play a role in the way that patients respond to drug therapies. Now an innovative study of migraine headache confirms that a patient's expectations – positive, negative or neutral – influence the effects of both a medication and a placebo.

Led by a research team at Beth Israel Deaconess Medical Center (BIDMC) and published on-line today in the journal Science Translational Medicine the study, for the first time, quantifies how much pain relief is attributed to a drug's pharmacological effect and how much to placebo effect, and demonstrates that a positive message and a powerful medication are both important for effective clinical care.

Senior authors Rami Burstein, PhD, Director of Pain Research in the Department of Anesthesia, Critical Care and Pain Medicine at BIDMC and Ted Kaptchuk, Director of the Program in Placebo Studies and Therapeutic Encounter (PiPS) at BIDMC and Harvard Medical School, took advantage of the recurring nature of migraine headaches to compare the effects of drug treatments and placebos in seven separate migraine attacks in each of 66 individuals. Their findings uncovered several key points: 1) The benefits of the migraine drug Maxalt (rizatriptan) increased when patients were told they were receiving an effective drug for the treatment of acute migraine; 2) When the identities of Maxalt tablets and placebo pills were switched, patients reported similar reductions in pain from placebo pills labeled as Maxalt as from Maxalt tablets labeled as placebo; and 3) Study subjects reported pain relief even when they knew the pill they were receiving was a placebo, compared with no treatment at all.

"One of the many implications of our findings is that when doctors set patients' expectations high, Maxalt [or, potentially, other migraine drugs] becomes more effective," says Burstein, the John Hedley-Whyte Professor of Anaesthesia at Harvard Medical School (HMS). "Increased effectiveness means shorter migraine attacks and shorter migraine attacks mean that less medication is needed," he adds.

"This study untangled and reassembled the clinical effects of placebo and medication in a unique manner," adds Kaptchuk, a Professor of Medicine at HMS. "Very few, if any, experiments have compared the effectiveness of medication under different degrees of information in a naturally recurring disease. Our discovery showing that subjects' reports of pain were nearly identical when they were told that an active drug was a placebo as when they were told that a placebo was an active drug demonstrates that the placebo effect is an unacknowledged partner for powerful medications."

The investigators studied over 450 attacks in 66 patients with migraines, throbbing headaches commonly accompanied by nausea, vomiting and sensitivity to light and sound. After an initial "no treatment" episode in which patients documented their headache pain and accompanying symptoms 30 minutes after headache onset and again two hours later (2.5 hours after onset), the participants were provided with six envelopes containing pills to be taken for each of their next six migraine attacks.

Of the six treatments, two were made with positive expectations (envelopes labeled "Maxalt"), two were made with negative expectations (envelopes labeled "placebo"), and two were made with neutral expectations (envelopes labeled "Maxalt or placebo"). In each of the three situations – positive, negative or neutral – one of the two envelopes contained a Maxalt tablet while the other contained a placebo, no matter what the label actually indicated. The patients then documented their pain experiences in the same manner as they had initially in the no-treatment session.

The results consistently showed that giving the pills accompanied by positive information incrementally boosted the efficacy of both the active migraine medication and the inert placebo.

"When patients received Maxalt labeled as placebo, they were being treated by the medication – but without any positive expectation," notes Burstein. "This was an attempt to isolate the pharmaceutical effect of Maxalt from any placebo effect." Conversely, the inert placebo labeled as Maxalt was an attempt to isolate the impact of the placebo effect from pharmaceutical effect.

Adds Kaptchuk, "Even though Maxalt was superior to the placebo in terms of alleviating pain, we found that under each of the three messages, the placebo effect accounted for at least 50 percent of the subjects' overall pain relief. When, for example, Maxalt was labeled 'Maxalt,' the subjects' reports of pain relief more than doubled compared to when Maxalt was labeled 'placebo.' This tells us that the effectiveness of a good pharmaceutical may be doubled by enhancing the placebo effect."

Furthermore, the authors were surprised to find that even when subjects were given a placebo that was labeled as "placebo," they reported pain relief, compared with no treatment.

"Contrary to conventional wisdom that patients respond to a placebo because they think they're getting an active drug, our findings reinforce the idea that open label placebo treatment may have a therapeutic benefit," say the authors, adding that while further research will be needed to explore how these findings could be applied to clinical care, the findings suggest that in the future placebos may provide a therapeutic boost to drug treatments.

INFORMATION:

In addition to senior authors Burstein and Kaptchuk, study coauthors include BIDMC investigators Slavenka Kam-Hansen of the Department of Neurology; Moshe Jakubowski of the Department of Anesthesia, Critical Care and Pain Medicine, John M. Kelley and Irving Kirsch of the PiPS, and consultant David C. Hoaglin.

This study was supported by a grant from Merck and Co., Inc. to Dr. Burstein, as well as grant support from the National Institutes of Health (R01 NS069847; R37 NS079678), and support from the NIH National Center for Complementary and Alternative Medicine (K24 AT004095); and Blue Guitar.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.

The BIDMC health care team includes Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Health Care, Commonwealth Hematology-Oncology, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Ancient Cambodian city's intensive land use led to extensive environmental impacts

2014-01-09
Ancient Cambodian city's intensive land use led to extensive environmental impacts Soil erosion may reveal ancient water management in Mahendraparvata Soil erosion and vegetation change indicate approximately 400 years of intensive land use around the city of Mahendraparvata ...

Neolithic mural may depict ancient eruption

2014-01-09
Neolithic mural may depict ancient eruption Volcanic rock age suggests Catalhoyuk mural may be based on Turkish eruption Volcanic rock dating suggests the painting of a Çatalhöyük mural may have overlapped with an eruption in Turkey according to results published ...

BOSS measures the universe to 1-percent accuracy

2014-01-09
BOSS measures the universe to 1-percent accuracy The Baryon Oscillation Spectroscopic Survey makes the most precise calibration yet of the universe's 'standard ruler' Today the Baryon Oscillation Spectroscopic Survey (BOSS) Collaboration announced that BOSS has ...

Tracking the deep sea paths of tiger sharks

2014-01-09
Tracking the deep sea paths of tiger sharks Understanding the habitat-use and migration patterns of large sharks Shark research scientist, Dr Jonathan Werry, has undertaken a four year study tracking the migratory patterns of tiger sharks (Galeocerdo cuvier) ...

Discovery brings scientists 1 step closer to understanding tendon injury

2014-01-09
Discovery brings scientists 1 step closer to understanding tendon injury Research led by Queen Mary University of London has discovered a specific mechanism that is crucial to effective tendon function, which could reveal why older people are more ...

Bacteria linked to water breaking prematurely during pregnancy

2014-01-09
Bacteria linked to water breaking prematurely during pregnancy DURHAM, N.C. – A high presence of bacteria at the site where fetal membranes rupture may be the key to understanding why some pregnant women experience their "water breaking" prematurely, ...

Bed bugs grow faster in groups

2014-01-09
Bed bugs grow faster in groups Researchers have previously observed that certain insects -- especially crickets, cockroaches and grasshoppers -- tend to grow faster when they live in groups. However, no research has ever been done on group living among bed ...

Elephant shark genome decoded

2014-01-09
Elephant shark genome decoded New insights gained into bone formation and immunity An international team of researchers has sequenced the genome of the elephant shark, a curious-looking fish with a snout that resembles the end of an elephant's ...

Symbiotic fungi inhabiting plant roots have major impact on atmospheric carbon, scientists say

2014-01-09
Symbiotic fungi inhabiting plant roots have major impact on atmospheric carbon, scientists say AUSTIN, Texas — Microscopic fungi that live in plants' roots play a major role in the storage and release of carbon from the soil into the atmosphere, according ...

New study finds extreme longevity in white sharks

2014-01-09
New study finds extreme longevity in white sharks Great white sharks—top predators throughout the world's ocean—grow much slower and live significantly longer than previously thought, according to a new study led by the Woods Hole Oceanographic ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Study finds that information is as important as medication in reducing migraine pain
Findings also show that patients report pain relief even when they know they are receiving a placebo